
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs2.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI) - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F39205000035AB07B52A3D.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="metabolites" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC7823877/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823877/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Metabolites" /><meta name="citation_title" content="Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)" /><meta name="citation_author" content="Elin Chorell" /><meta name="citation_author_institution" content="Department of Public Health and Clinical Medicine, Ume&#x000e5; University, SE-901 87 Ume&#x000e5;, Sweden; es.umu@nosslo.g.ymmot" /><meta name="citation_author" content="Tommy Olsson" /><meta name="citation_author_institution" content="Department of Public Health and Clinical Medicine, Ume&#x000e5; University, SE-901 87 Ume&#x000e5;, Sweden; es.umu@nosslo.g.ymmot" /><meta name="citation_author" content="Jan-H&#x000e5;kan Jansson" /><meta name="citation_author_institution" content="Research Unit Skellefte&#x000e5;, Department of Public Health and Clinical Medicine, Ume&#x000e5; University, 90187 Ume&#x000e5;, Sweden; es.nettobretsavnoiger@nossnaj.nakahnaj" /><meta name="citation_author" content="Patrik Wennberg" /><meta name="citation_author_institution" content="Department of Public Health and Clinical Medicine, Family Medicine, Medicine, Ume&#x000e5; University, 90187 Ume&#x000e5;, Sweden; es.umu@grebnnew.kirtap" /><meta name="citation_publication_date" content="2021/01" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="11" /><meta name="citation_doi" content="10.3390/metabo11010025" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC7823877/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC7823877/" /><meta name="citation_pmid" content="33396480" /><meta name="DC.Title" content="Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Multidisciplinary Digital Publishing Institute  (MDPI)" /><meta name="DC.Contributor" content="Elin Chorell" /><meta name="DC.Contributor" content="Tommy Olsson" /><meta name="DC.Contributor" content="Jan-H&#x000e5;kan Jansson" /><meta name="DC.Contributor" content="Patrik Wennberg" /><meta name="DC.Date" content="2021 Jan" /><meta name="DC.Identifier" content="10.3390/metabo11010025" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)" /><meta property="og:type" content="article" /><meta property="og:description" content="The present study explored patterns of circulating metabolites and proteins that can predict future risk for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). We conducted a prospective nested case-control ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823877/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7823877/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Metabolites%22[journal]" class="navlink">Metabolites</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7823877
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC7823877/pdf/metabolites-11-00025.pdf" class="int-view">PDF (2.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7823877/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7823877/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="7823877" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7823877%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="jMtTggGlnGU5ByT6Le6AS9rmd60VX3vjI8OmcJcfy98ZGcVIayRcD55dYHMMbD3L">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7823877%2F&amp;text=Lysophospholipids%20as%20Predictive%20Markers%20of%20ST-Elevation%20Myocardial%20Infarction%20(STEMI)%20and%20Non-ST-Elevation%20Myocardial%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7823877%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823877/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7823877/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/33396480/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7823877/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/33396480/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7823877/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7823877/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Metabolites%22[journal]" class="navlink">Metabolites</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7823877
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-metabolites.png" alt="Logo of metabolites" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.mdpi.com/journal/metabolites" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Metabolites.</span> 2021 Jan; 11(1): 25. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2020 Dec 31. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3390%2Fmetabo11010025" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3390/metabo11010025</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC7823877</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33396480">33396480</a></div></div></div><h1 class="content-title">Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chorell%20E%5BAuthor%5D" class="affpopup" co-rid="_co_idm139930396737504" co-class="co-affbox">Elin Chorell</a>,<sup>1,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Olsson%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm139930402423328" co-class="co-affbox">Tommy Olsson</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jansson%20JH%5BAuthor%5D" class="affpopup" co-rid="_co_idm139930396734352" co-class="co-affbox">Jan-H&#x000e5;kan Jansson</a>,<sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wennberg%20P%5BAuthor%5D" class="affpopup" co-rid="_co_idm139930397865248" co-class="co-affbox">Patrik Wennberg</a><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139930396737504"><h3 class="no_margin">Elin Chorell</h3><p><sup>1</sup>Department of Public Health and Clinical Medicine, Ume&#x000e5; University, SE-901 87 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.umu@nosslo.g.ymmot" class="oemail">es.umu@nosslo.g.ymmot</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chorell%20E%5BAuthor%5D">Elin Chorell</a></div></div><div id="_co_idm139930402423328"><h3 class="no_margin">Tommy Olsson</h3><p><sup>1</sup>Department of Public Health and Clinical Medicine, Ume&#x000e5; University, SE-901 87 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.umu@nosslo.g.ymmot" class="oemail">es.umu@nosslo.g.ymmot</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Olsson%20T%5BAuthor%5D">Tommy Olsson</a></div></div><div id="_co_idm139930396734352"><h3 class="no_margin">Jan-H&#x000e5;kan Jansson</h3><p><sup>2</sup>Research Unit Skellefte&#x000e5;, Department of Public Health and Clinical Medicine, Ume&#x000e5; University, 90187 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.nettobretsavnoiger@nossnaj.nakahnaj" class="oemail">es.nettobretsavnoiger@nossnaj.nakahnaj</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jansson%20JH%5BAuthor%5D">Jan-H&#x000e5;kan Jansson</a></div></div><div id="_co_idm139930397865248"><h3 class="no_margin">Patrik Wennberg</h3><p><sup>3</sup>Department of Public Health and Clinical Medicine, Family Medicine, Medicine, Ume&#x000e5; University, 90187 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.umu@grebnnew.kirtap" class="oemail">es.umu@grebnnew.kirtap</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wennberg%20P%5BAuthor%5D">Patrik Wennberg</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm139930412843216_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139930412843216_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139930412843216_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm139930412843216_ai" style="display:none"><div class="fm-affl" id="af1-metabolites-11-00025"><sup>1</sup>Department of Public Health and Clinical Medicine, Ume&#x000e5; University, SE-901 87 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.umu@nosslo.g.ymmot" class="oemail">es.umu@nosslo.g.ymmot</a></div><div class="fm-affl" id="af2-metabolites-11-00025"><sup>2</sup>Research Unit Skellefte&#x000e5;, Department of Public Health and Clinical Medicine, Ume&#x000e5; University, 90187 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.nettobretsavnoiger@nossnaj.nakahnaj" class="oemail">es.nettobretsavnoiger@nossnaj.nakahnaj</a></div><div class="fm-affl" id="af3-metabolites-11-00025"><sup>3</sup>Department of Public Health and Clinical Medicine, Family Medicine, Medicine, Ume&#x000e5; University, 90187 Ume&#x000e5;, Sweden; <a href="mailto:dev@null" data-email="es.umu@grebnnew.kirtap" class="oemail">es.umu@grebnnew.kirtap</a></div><div id="c1-metabolites-11-00025"><sup>*</sup>Correspondence: <a href="mailto:dev@null" data-email="es.umu@llerohc.nile" class="oemail">es.umu@llerohc.nile</a>; Tel.: +46-(0)90-785-1326</div></div><div class="fm-article-notes hide half_rhythm" id="idm139930412843216_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2020 Nov 25; Accepted 2020 Dec 28.</div></div><div class="permissions half_rhythm hide" id="idm139930412843216_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2020 by the authors.</div><div class="license half_rhythm">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="http://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div><a href="/pmc/articles/PMC7823877/bin/metabolites-11-00025-s001.zip" data-ga-action="click_feat_suppl">metabolites-11-00025-s001.zip</a><span style="color:gray"> (5.7M)</span></div><div class="small guid">GUID: 836D1D82-A86B-4455-8B43-06E4F83959B9</div></div></dd></dl><dl data-length="34" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>Data will be available on request.</p></dd></dl></div><div id="abstract-a.i.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.i.b.rtitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">The present study explored patterns of circulating metabolites and proteins that can predict future risk for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). We conducted a prospective nested case-control study in northern Sweden in individuals who developed STEMI (N = 50) and NSTEMI (N = 50) within 5 years and individually matched controls (N = 100). Fasted plasma samples were subjected to multiplatform mass spectrometry-based metabolomics and multiplex protein analyses. Multivariate analyses were used to elucidate infarction-specific metabolite and protein risk profiles associated with future incident STEMI and NSTEMI. We found that altered lysophosphatidylcholine (LPC) to lysophosphatidylethanolamine (LPE) ratio predicted STEMI and NSTEMI events in different ways. In STEMI, lysophospholipids (mainly LPEs) were lower, whereas in NSTEMI, lysophospholipids (mainly LPEs) were higher. We found a similar response for all detected lysophospholipids but significant alterations only for those containing linoleic acid (C18:2, <em>p</em> &#x0003c; 0.05). Patients with STEMI had higher secretoglobin family 3A member 2 and tartrate-resistant acid phosphate type 5 and lower platelet-derived growth factor subunit A, which are proteins associated with atherosclerosis severity and plaque development mediated via altered phospholipid metabolism. In contrast, patients with NSTEMI had higher levels of proteins associated with inflammation and macrophage activation, including interleukin 6, C-reactive protein, chemerin, and cathepsin X and D. The STEMI risk marker profile includes factors closely related to the development of unstable plaque, including a higher LPC:LPE ratio, whereas NSTEMI is characterized by a lower LPC:LPE ratio and increased inflammation.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">myocardial infarction, ST-elevation, non-ST-elevation, metabolomics, plasma protein, lysophospholipids, prediction, risk factors</span></div></div><div id="sec1-metabolites-11-00025" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1-metabolites-11-00025title">1. Introduction</h2><p class="p p-first">Acute coronary syndrome is characterized by a sudden reduction in blood flow to the heart and is the leading cause of morbidity and mortality globally [<a href="#B1-metabolites-11-00025" rid="B1-metabolites-11-00025" class=" bibr popnode">1</a>,<a href="#B2-metabolites-11-00025" rid="B2-metabolites-11-00025" class=" bibr popnode">2</a>]. Patients with acute coronary syndrome can be diagnosed and classified into two types of myocardial infarction based on their electrocardiographic profile: ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI). Typically, STEMI patients suffer from a ruptured plaque and total coronary occlusion with ensuing ischemia that affects the entire thickness of the myocardium, whereas NSTEMI patients have more stable vessel lesions associated with incomplete blood flow in the coronary artery, resulting in ischemia mainly within the inner region of the myocardium [<a href="#B3-metabolites-11-00025" rid="B3-metabolites-11-00025" class=" bibr popnode">3</a>,<a href="#B4-metabolites-11-00025" rid="B4-metabolites-11-00025" class=" bibr popnode">4</a>]. Gene polymorphisms linked to instability in atherosclerotic plaques have been found in STEMI patients, whereas NSTEMI patients are older, more often previously diagnosed with hypertension, diabetes, and atherosclerotic disease and are at higher risk of recurrent ischemic events [<a href="#B5-metabolites-11-00025" rid="B5-metabolites-11-00025" class=" bibr popnode">5</a>]. However, available prognostic risk markers, such as the Framingham Risk Score [<a href="#B6-metabolites-11-00025" rid="B6-metabolites-11-00025" class=" bibr popnode">6</a>], give a rough estimate of individual risk prediction. Therefore, it is of major interest to identify new prognostic markers for myocardial infarction, and specifically for STEMI and NSTEMI, to further optimize and personalize prevention and treatment [<a href="#B7-metabolites-11-00025" rid="B7-metabolites-11-00025" class=" bibr popnode">7</a>].</p><p class="p p-last">Bioactive lipids are potent mediators of genetic and lifestyle factors that increase the susceptibility to cardiovascular disease (CVD) and complications, such as myocardial infarction [<a href="#B8-metabolites-11-00025" rid="B8-metabolites-11-00025" class=" bibr popnode">8</a>]. Thus, lysophospholipids are of specific interest because they can exert multiple activities in blood cells and cells in the vessel wall [<a href="#B9-metabolites-11-00025" rid="B9-metabolites-11-00025" class=" bibr popnode">9</a>] and may directly or indirectly mediate the progression of CVD [<a href="#B10-metabolites-11-00025" rid="B10-metabolites-11-00025" class=" bibr popnode">10</a>] and also contribute to atherosclerotic plaque instability [<a href="#B11-metabolites-11-00025" rid="B11-metabolites-11-00025" class=" bibr popnode">11</a>]. Importantly, total plasma phospholipid levels may not be sufficient to predict cardiovascular events, as the thrombogenicity and atherogenicity of phospholipids depends on their composition (i.e., head group, ester or ether backbone, and the saturation and carbon length of the attached fatty acid). Thus, the interpretation of total lipid content, even of a specific lipid subtype, can be misleading and yield contradictory results. In this study, we explored plasma metabolites, including lysophospholipids, and proteins to elucidate a myocardial risk signature that differs between STEMI and NSTEMI 5 years on average prior to an event.</p></div><div id="sec2-metabolites-11-00025" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2-metabolites-11-00025title">2. Results</h2><div id="sec2dot1-metabolites-11-00025" class="sec sec-first"><h3 id="sec2dot1-metabolites-11-00025title">2.1. Cohort Characteristics</h3><p class="p p-first-last">The characteristics of the study population are shown in <a href="/pmc/articles/PMC7823877/table/metabolites-11-00025-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-t001" rid-ob="ob-metabolites-11-00025-t001" co-legend-rid=""><span>Table 1</span></a>. At sampling, the NSTEMI group was older than the STEMI group (47 years vs. 51 years, respectively), and the proportion of males was higher in the STEMI group (96% vs. 86%, <em>p</em> &#x0003c; 0.05). In addition, NSTEMI patients had significantly higher BMI (<em>p</em> = 0.004) than their control group. The mean time between the health examination and event was 4 years and 10 months (range 1.4&#x02013;122.1 months) and was similar in the STEMI and NSTEMI groups. No change in lipoprotein(a) were observed between infarction groups and their matched control group (data not shown) [<a href="#B12-metabolites-11-00025" rid="B12-metabolites-11-00025" class=" bibr popnode">12</a>].</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="metabolites-11-00025-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Baseline characteristics of the cases and referents with ST-elevation myocardial infarction (STEMI) and non ST-elevation myocardial infarction (NSTEMI).</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin" rowspan="1">STEMI</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin" rowspan="1">NSTEMI</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases (<em>n</em> = 50)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Referents (<em>n</em> = 50)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><em>p</em>-Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases (<em>n</em> = 50)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Referents (<em>n</em> = 50)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><em>p</em>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age at screening, years</td><td align="center" valign="middle" rowspan="1" colspan="1">42.0 (5.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">42.1 (5.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.91</td><td align="center" valign="middle" rowspan="1" colspan="1">45.8 (5.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">45.8 (5.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age at MI/SCD, years</td><td align="center" valign="middle" rowspan="1" colspan="1">46.8 (5.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">50.6 (5.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sex (% male)</td><td align="center" valign="middle" rowspan="1" colspan="1">96</td><td align="center" valign="middle" rowspan="1" colspan="1">96</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">86</td><td align="center" valign="middle" rowspan="1" colspan="1">86</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smoking (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">48</td><td align="center" valign="middle" rowspan="1" colspan="1">10.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">42.9</td><td align="center" valign="middle" rowspan="1" colspan="1">15.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">46</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Low level of education (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67</td><td align="center" valign="middle" rowspan="1" colspan="1">42.6</td><td align="center" valign="middle" rowspan="1" colspan="1">25.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup>
<sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">26.6 (4.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">25.5 (3.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">27.1 (4.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">25.3 (4.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SBT, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">135.8 (14.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">131.2 (14.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">132.7 (13.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">128.9 (12.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">DBT, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">88.4 (11.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">83.1 (9.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">87.3 (9.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">82.5 (9.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.013</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesterol, mmol/L</td><td align="center" valign="middle" rowspan="1" colspan="1">6.27 (1.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.97 (1.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21</td><td align="center" valign="middle" rowspan="1" colspan="1">6.68 (0.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.13 (1.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Glucose, mmol/L <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.10 (0.90)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.16 (0.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" rowspan="1" colspan="1">5.10 (1.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.28 (0.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CRP, ng/L <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.15 (1.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (2.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81</td><td align="center" valign="middle" rowspan="1" colspan="1">2.29 (3.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.06 (1.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ApoB/apoA1 ratio</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.33)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.79 (0.21)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 (0.24)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82 (0.26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139930403455328"><a target="object" rel="noopener" href="/pmc/articles/PMC7823877/table/metabolites-11-00025-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.e.e.a"><p class="p p-first-last">MI, myocardial infarction; sudden cardiac death (SCD); BMI, body mass index; SBT, systolic blood pressure; SBT, systolic blood pressure; DBT, diastolic blood pressure; CRP, C-reactive protein. Data are given as proportions (%), mean value and standard deviation, or <sup>a</sup> median and interquartile range. Low level of education refers to 9 years of compulsory education.</p></div></div></div></div><div id="sec2dot2-metabolites-11-00025" class="sec"><h3 id="sec2dot2-metabolites-11-00025title">2.2. Metabolomics and Protein Panel Analysis</h3><p class="p p-first-last">The combined approach with GC-TOF/MS and LC-TOF/MS provided comprehensive coverage of serum metabolites with different chemical properties. From the mass spectrometry analyses, we detected 1140 putative metabolites, 169 of which were annotated, along with 92 proteins from the multiplex panel. All annotated metabolites and proteins are listed in <a href="#app1-metabolites-11-00025" rid="app1-metabolites-11-00025" class=" app">Supplementary Table S1</a>. No outliers were found in PCA of the complete dataset (data not shown). Because of the over-representation of men in this cohort, we performed the same analyses excluding women and found no change in risk metabolite and protein profile (data not shown).</p></div><div id="sec2dot3-metabolites-11-00025" class="sec"><h3 id="sec2dot3-metabolites-11-00025title">2.3. Infarction Risk Metabolite Profiles</h3><p class="p p-first">We found that the infarction-specific plasma metabolite risk profiles differed significantly between the infarction groups and their individually matched controls (OPLS-EP, CV-ANOVA, <em>p</em> &#x0003c; 0.002, <a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001" co-legend-rid="lgnd_metabolites-11-00025-f001"><span>Figure 1</span></a>). Both infarction groups exhibited significantly altered lysophospholipids, branched-chain amino acids, and acylcarnitines. The lysophospholipid metabolite pattern differed between infarction groups; patients with STEMI had higher LPC:LPE ratios, whereas NSTEMIs had lower ratios than the matched controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001" co-legend-rid="lgnd_metabolites-11-00025-f001"><span>Figure 1</span></a>). The LPC:LPE ratio that included linoleic acid (i.e., LPC:LPE(18:2)) was significantly altered in both myocardial infarction groups compared to matched controls, but in an opposite manner (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f002/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f002" rid-ob="ob-metabolites-11-00025-f002" co-legend-rid="lgnd_metabolites-11-00025-f002"><span>Figure 2</span></a>). In addition to an altered 18:2 ratio, NSTEMI had a significantly lower 16:0 ratio (i.e., LPC:LPE(16:0)). The underlying reason for the altered LPC:LPE ratio differed between infarction groups. Compared to controls, STEMI had lower levels of LPEs and LPCs, but the former to a greater extent, which causes a higher LPC:LPE ratio (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f002/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f002" rid-ob="ob-metabolites-11-00025-f002" co-legend-rid="lgnd_metabolites-11-00025-f002"><span>Figure 2</span></a>c, CV-ANOVA <em>p</em> &#x0003c; 0.05). In contrast, patients with NSTEMI had higher LPE levels, resulting in lower LPC:LPE ratios compared to matched controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f002/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f002" rid-ob="ob-metabolites-11-00025-f002" co-legend-rid="lgnd_metabolites-11-00025-f002"><span>Figure 2</span></a>d, OPLS CV-ANOVA <em>p</em> &#x0003c; 0.05, and <em>t</em> test <em>p</em> &#x0003c; 0.05). We also detected a significant difference in several platelet activating factors (PAFs) in both infarction groups compared to their matched controls. PAFs containing eicosatrienoic acid (C20:3) and palmitoleic acid (C16:1) were higher in NSTEMI, whereas PAFs containing linolenic acid (C18:3) were lower in STEMI compared to matched controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001" co-legend-rid="lgnd_metabolites-11-00025-f001"><span>Figure 1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="metabolites-11-00025-f001" co-legend-rid="lgnd_metabolites-11-00025-f001"><a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139930407195888"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7823877_metabolites-11-00025-g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is metabolites-11-00025-g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7823877/bin/metabolites-11-00025-g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139930407195888"><a target="object" rel="noopener" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_metabolites-11-00025-f001"><div><a class="figpopup" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001">Figure 1</a></div><!--caption a7--><div class="caption"><p>Infarction-specific multivariate models (OPLS-EP) calculated from plasma metabolomics. Annotated parameters that were significantly (<em>p</em> &#x0003c; 0.05) different between cases and their matched controls are included. (<strong>A</strong>) STEMI metabolite risk profile. (<strong>B</strong>) NSTEMI metabolite risk profile. The multivariate confidence intervals indicate significance on a 95% based on jack-knifing.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="metabolites-11-00025-f002" co-legend-rid="lgnd_metabolites-11-00025-f002"><a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f002/" target="figure" rid-figpopup="metabolites-11-00025-f002" rid-ob="ob-metabolites-11-00025-f002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139930407947888"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7823877_metabolites-11-00025-g002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is metabolites-11-00025-g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7823877/bin/metabolites-11-00025-g002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139930407947888"><a target="object" rel="noopener" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_metabolites-11-00025-f002"><div><a class="figpopup" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f002/" target="figure" rid-figpopup="metabolites-11-00025-f002" rid-ob="ob-metabolites-11-00025-f002">Figure 2</a></div><!--caption a7--><div class="caption"><p>Raw data describing the relative concentration of lysophospholipid ratios with different fatty acid composition. (<strong>a</strong>) STEMI patients (white bars) and (<strong>b</strong>) NSTEMI patients (white bars) compared to their respective controls (grey bars). LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine. ** Ratios that are significantly altered between cases and controls in multivariate models and univariate <em>t</em> tests. * Ratios that are significantly altered only in univariate analysis based on a 95% confidence level. Confidence intervals are calculated on a 95% confidence levels using Student&#x02019;s t-test. (<strong>c</strong>) The higher LPC:LPE ratios in STEMI are caused by lower LPCs and especially LPEs. (<strong>d</strong>) Lower LPC:LPE ratios in NSTEMI are caused by higher LPEs and no difference in LPCs compared to matched controls (CV-ANOVA <em>p</em> &#x0003c; 0.05).</p></div></div></div><p class="p p-last">The branched-chain amino acids and acylcarnitine risk pattern also differed between the two infarction groups. In the STEMI group, we found significantly higher isoleucine/leucine levels (not separated due to confounded peaks in the mass spectra), along with their catabolic intermediate isovalerylcarnitine (C5iso-carnitine), and higher levels of acylcarnitine (C2-carnitine) and hexaonylcarnitine (C6-carnitine) compared to controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001" co-legend-rid="lgnd_metabolites-11-00025-f001"><span>Figure 1</span></a>A). In the NSTEMI group, we found higher levels of glutamic acid, carnitine, acylcarnitines (C16:0-carnitine, C4-carnitine), and the branched-chain amino acid valine compared to controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f001" rid-ob="ob-metabolites-11-00025-f001" co-legend-rid="lgnd_metabolites-11-00025-f001"><span>Figure 1</span></a>B).</p></div><div id="sec2dot4-metabolites-11-00025" class="sec sec-last"><h3 id="sec2dot4-metabolites-11-00025title">2.4. Infarction Risk Protein Profiles</h3><p class="p p-first">Among the circulating proteins covered by the protein panel, we found a significantly altered protein risk profile for both infarction groups compared to their matched control groups (CV-ANOVA <em>p</em> &#x0003c; 0.05). For both infarction groups, we found significantly higher levels of interleukin-2 receptor subunit alpha (IL2-RA) and growth/differentiation factor-15 (GDF-15). In patients with STEMI, we found significantly altered proteins associated with phospholipid metabolism, specifically higher tartrate-resistant acid phosphatase type 5 (TR-AP) and secretoglobin family 3A member 2 (SCGB3A2) and lower platelet-derived growth factor subunit A (PDGF-A), compared to controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f003/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f003" rid-ob="ob-metabolites-11-00025-f003" co-legend-rid="lgnd_metabolites-11-00025-f003"><span>Figure 3</span></a>A). In contrast, in patients with NSTEMI, we found higher levels of proteins associated with inflammation and macrophage activation, specifically interleukin 6 (IL6), C-reactive protein (CRP), chemerin, cathepsin X and D, cluster of differentiation 163 (CD163), beta-cell activating factor (BAFF), and the chemokine c-c motif chemokine 16 (CXCL16).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="metabolites-11-00025-f003" co-legend-rid="lgnd_metabolites-11-00025-f003"><a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f003/" target="figure" rid-figpopup="metabolites-11-00025-f003" rid-ob="ob-metabolites-11-00025-f003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139930450622784"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7823877_metabolites-11-00025-g003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is metabolites-11-00025-g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7823877/bin/metabolites-11-00025-g003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139930450622784"><a target="object" rel="noopener" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_metabolites-11-00025-f003"><div><a class="figpopup" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f003/" target="figure" rid-figpopup="metabolites-11-00025-f003" rid-ob="ob-metabolites-11-00025-f003">Figure 3</a></div><!--caption a7--><div class="caption"><p>Infarction-specific multivariate models (OPLS-EP) calculated from the multiplex protein panel. Only proteins that are significantly (<em>p</em> &#x0003c; 0.05) altered between cases and their matched controls are shown. (<strong>A</strong>) STEMI protein risk profile. (<strong>B</strong>) NSTEMI protein risk profile. The multivariate confidence intervals indicate significance on a 95% based on jack-knifing.</p></div></div></div><p class="p p-last">In addition, the NSTEMI group had higher levels of the low-density lipoprotein (LDL) receptor, tissue factor pathway inhibitor (TFPI), tissue plasminogen activator (tPA), and von Willebrand factor (vWF) compared to controls (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f003/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f003" rid-ob="ob-metabolites-11-00025-f003" co-legend-rid="lgnd_metabolites-11-00025-f003"><span>Figure 3</span></a>B).</p></div></div><div id="sec3-metabolites-11-00025" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3-metabolites-11-00025title">3. Discussion</h2><p class="p p-first">This study highlights a unique circulating metabolite and protein risk signature for STEMI that includes metabolites and proteins associated with altered lysophospholipid metabolism. These metabolites and proteins have been shown to be associated with increased thrombosis and plaque development. Specifically, we show that the lysophospholipid ratio containing 18:2 fatty acid is altered in a different manner between STEMI and NSTEMI than matched controls. The differences in the risk marker profile between STEMI and NSTEMI may contribute to the development of novel risk scores for different myocardial infarction subtypes and increase our understanding of the underlying mechanisms, which can improve treatment efficacy.</p><p>It is becoming increasingly clear that dysfunctional lipid metabolism extends far beyond cholesterol and triglycerides. Lysophospholipids are potent mediators of inflammatory reactions and play an important role in the pathophysiology of acute coronary syndromes [<a href="#B13-metabolites-11-00025" rid="B13-metabolites-11-00025" class=" bibr popnode">13</a>]. Specific phospholipid subtypes, such as LPCs, play a key role in plaque inflammation and vulnerability [<a href="#B11-metabolites-11-00025" rid="B11-metabolites-11-00025" class=" bibr popnode">11</a>]. However, data on specific lysophospholipid subtypes are lacking in humans.</p><p>We show that prior to the myocardial infarction event, patients with STEMI had higher LPC:LPE ratios, especially those containing linoleic acid (C18:2), compared to matched controls. Previous studies have shown that the C18:2 lysophospholipids are strongly associated with blood clotting activities by increased conversion of C18:2 LPC to C18:2 lysophosphatic acids via autotaxin mediation [<a href="#B14-metabolites-11-00025" rid="B14-metabolites-11-00025" class=" bibr popnode">14</a>]. Furthermore, earlier studies suggested an association between plaque severity and lysophosphatic acids [<a href="#B9-metabolites-11-00025" rid="B9-metabolites-11-00025" class=" bibr popnode">9</a>]. However, these studies were performed in vitro or after plaque rupture, not prior to infarction. As lysophosphatic acids are imbedded in plaques/foam cells or produced during vascular injury post-infarction/plaque rupture, its precursors, such as LPC and LPE, should be more relevant predictors of risk. This finding is in line with recent data indicating an association between circulating LPCs and atherosclerotic plaque instability via platelet activation and aggregation in both mice and humans [<a href="#B11-metabolites-11-00025" rid="B11-metabolites-11-00025" class=" bibr popnode">11</a>]. We show that both LPCs and LPEs are lower in STEMI but LPCs to a greater extent than LPEs. This is what causes the higher LPC:LPE ratio in patients with STEMI compared to matched healthy controls. Additionally included in the STEMI-risk profile was lower PAF(18:3) compared to controls, which may relate to increased vessel uptake and aggregation.</p><p>The lysophospholipid findings are supported in the protein risk profile, in which patients with STEMI exhibit alteration of phospholipid-mediated proteins associated with increased calcification and the number of diseased vessels (TR-AP) [<a href="#B15-metabolites-11-00025" rid="B15-metabolites-11-00025" class=" bibr popnode">15</a>], inhibition of lysophospholipid metabolism (SCGB3A2) [<a href="#B16-metabolites-11-00025" rid="B16-metabolites-11-00025" class=" bibr popnode">16</a>], and plaque formation (PDGF-A) [<a href="#B17-metabolites-11-00025" rid="B17-metabolites-11-00025" class=" bibr popnode">17</a>]. Thus, our observation of lower LPCs and LPEs in STEMI compared to controls, specifically those containing C18:2 fatty acid, could be related to an increased conversion of LPCs and LPEs to lysophosphatic acids via autotaxin and be a sign of plaque formation and plaque severity/instability. Notably, we did not measure circulating lysophosphatic acids, which should be explored in future studies.</p><p>Lysophospholipids can be generated from glycerolipid hydrolysis, via cholesteryl esterases, and this process is greatly enhanced by the presence of bile acids [<a href="#B18-metabolites-11-00025" rid="B18-metabolites-11-00025" class=" bibr popnode">18</a>]. In agreement with this, we show that STEMI has higher levels of secondary conjugated bile acid taurodeoxycholic acid (TDCA). In addition, endogenous bile acid has been shown to modulate cell death by interrupting apoptotic pathways, and bile acid supplementation has been shown to reduce infarct size and improve neurological function in rodent brain models [<a href="#B19-metabolites-11-00025" rid="B19-metabolites-11-00025" class=" bibr popnode">19</a>]. Thus, the higher TDCA and betaine could be an attempt to protect against bile-induced apoptosis via inhibition of the proapoptotic mitochondrial pathway [<a href="#B20-metabolites-11-00025" rid="B20-metabolites-11-00025" class=" bibr popnode">20</a>].</p><p>In contrast to STEMI, patients with NSTEMI had higher levels of LPCs and LPEs in addition to higher levels of proteins associated with inflammation and macrophage activation (i.e., IL6, CRP, chemerin, cathepsin X and D, CD163, BAFF, and CXCL16). Together with the higher BMI in patients with NSTEMI, this finding indicates obesity-driven mechanisms that include increased circulating low-grade inflammation and macrophage activation in adipose tissue [<a href="#B21-metabolites-11-00025" rid="B21-metabolites-11-00025" class=" bibr popnode">21</a>].</p><p>Phospholipid homeostasis, specifically the ratio between ethanolamine- and choline-containing phospholipids, has implications in vascular wall function, as well as tissue lipid mobilization and calcium homeostasis [<a href="#B22-metabolites-11-00025" rid="B22-metabolites-11-00025" class=" bibr popnode">22</a>]. Interestingly, both LPC and LPE have been shown to be altered in patients with angina or myocardial infarction, especially those with an increased inflammatory profile [<a href="#B23-metabolites-11-00025" rid="B23-metabolites-11-00025" class=" bibr popnode">23</a>]. As LPC and LPE are synthesized in parallel and share enzymatic steps, an altered ratio indicates altered phospholipid metabolism and is highly associated with various metabolic disorders, including atherosclerosis [<a href="#B24-metabolites-11-00025" rid="B24-metabolites-11-00025" class=" bibr popnode">24</a>]. Altered lysophospholipids may reflect effects on energy metabolism, steatosis, and membrane integrity, as their precursors are vital components in cell membranes and required for very low-density lipoprotein (VLDL) secretion [<a href="#B24-metabolites-11-00025" rid="B24-metabolites-11-00025" class=" bibr popnode">24</a>]. Obesity and an oversupply of fatty acids are also suggested to contribute to a skewed phospholipid ratio, which could explain, at least in part, the higher levels of lysophospholipids observed in the more obese patients with NSTEMI compared to controls.</p><p>Concurrent with higher levels of lysophospholipids, we show higher sphingosine-1-phosphate (S1P) in NSTEMI, which regulates the important functions in cardiac and vascular homeostasis. The majority of plasma S1P seems to originate from high-density lipoprotein (HDL), and the S1P content in HDL is associated with various cardio-protective effects [<a href="#B25-metabolites-11-00025" rid="B25-metabolites-11-00025" class=" bibr popnode">25</a>]. In contrast, S1P has been shown to increase during vascular calcification, which could be prevented by inhibition of S1P formation [<a href="#B26-metabolites-11-00025" rid="B26-metabolites-11-00025" class=" bibr popnode">26</a>]. Interestingly, myocardial cells express both enzymes and receptors involved in sphingolipid metabolism and, thus, are able to synthesize and respond to sphingolipid metabolites, such as S1P. However, sphingolipids seem to be involved in many different pathophysiological processes that directly or indirectly affect cardiovascular functions [<a href="#B27-metabolites-11-00025" rid="B27-metabolites-11-00025" class=" bibr popnode">27</a>].</p><p>We also show that NSTEMI has higher levels of valine, a branched-chained amino acid commonly associated with obesity [<a href="#B28-metabolites-11-00025" rid="B28-metabolites-11-00025" class=" bibr popnode">28</a>]. Glutamic acid is also significantly higher in patients with NSTEMI, which can indicate an increased conversion of glutamine to glutamic acid to maintain nicotinamide adenine dinucleotide-H (NADH) levels and TCA intermediates and compensate for ischemic/anoxic events prior to infarction [<a href="#B29-metabolites-11-00025" rid="B29-metabolites-11-00025" class=" bibr popnode">29</a>].</p><p>We found higher acylcarnitine levels in both infarction groups, which mainly reflects alteration of transport acyl compounds. Trans-membrane transportation of most fatty acids, and some other metabolites, occurs mostly via the carnitine shuttle, which regulates the flux of CoA-activated metabolites via acylcarnitines into the mitochondria, where they undergo &#x003b2;-oxidation [<a href="#B30-metabolites-11-00025" rid="B30-metabolites-11-00025" class=" bibr popnode">30</a>]. As acylcarnitines are found outside tissues, this suggests that their efflux may serve as a detoxification process to increase metabolic flexibility and prevent CoA-trapping, allowing CoA-dependent metabolic processes to continue, including the tricarboxylic acid cycle (TCA) and &#x003b2;-oxidation [<a href="#B31-metabolites-11-00025" rid="B31-metabolites-11-00025" class=" bibr popnode">31</a>,<a href="#B32-metabolites-11-00025" rid="B32-metabolites-11-00025" class=" bibr popnode">32</a>].</p><p>We acknowledge that the fasted metabolite signatures are highly confounded by numerous lifestyle factors, and all results from this study should be validated in an independent cohort. The relatively young study group (mean age 44 years at diagnosis) may restrict the generalizability of our findings but it may also imply less confounding, in comparison with an older age group, due to coexisting disorders. Our results should also be further explored in patients with chronic coronary syndrome. Notably, male individuals were over-represented (82% male) among subjects with myocardial infarction in northern Sweden [<a href="#B12-metabolites-11-00025" rid="B12-metabolites-11-00025" class=" bibr popnode">12</a>] during this sampling period, which is also reflected in this material. Statin usage is a potential confounder when studying circulating lipids and metabolites. However, this is unlikely in our study cohort that had a very low statins usage (1.4%) [<a href="#B33-metabolites-11-00025" rid="B33-metabolites-11-00025" class=" bibr popnode">33</a>].</p><p class="p p-last">Our results suggest that further lipid screening should focus on phospholipids and lysophospholipid-related lipids and lipoproteins to increase our understanding of underlying mechanisms and improve risk assessment and treatment efficacy. In addition, future analyses should also incorporate analyses of lipid isomerization since this is potentially of key importance for their ability to interact with receptors and biological activity. This study also highlights the vast complexity and multiple mechanisms underlying myocardial infarction and the need to consider a risk profile rather than single markers to reduce false-negatives, improve risk assessment, and reduce mortality.</p></div><div id="sec4-metabolites-11-00025" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4-metabolites-11-00025title">4. Materials and Methods</h2><p class="p p-first">The study population was derived from the V&#x000e4;sterbotten Intervention Programme (VIP) [<a href="#B34-metabolites-11-00025" rid="B34-metabolites-11-00025" class=" bibr popnode">34</a>] and the WHO&#x02019;s Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study in northern Sweden [<a href="#B35-metabolites-11-00025" rid="B35-metabolites-11-00025" class=" bibr popnode">35</a>]. Both VIP and MONICA included health examination programmes for CVD and diabetes with average participation rates of 59% and 77%, respectively. These studies have standardized the collection and storage procedures for metabolomics analyses and include approximately 100,000 individuals with blood samples stored in the Ume&#x000e5; Medical Biobank. The designs of VIP and MONICA were described in detail previously [<a href="#B34-metabolites-11-00025" rid="B34-metabolites-11-00025" class=" bibr popnode">34</a>,<a href="#B35-metabolites-11-00025" rid="B35-metabolites-11-00025" class=" bibr popnode">35</a>]. In northern Sweden (the counties of V&#x000e4;sterbotten and Norrbotten), all myocardial infarction events among those aged 18&#x02013;64 years between 1985 and 1999 were registered in the population-based MONICA registry (<a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f004/" target="figure" class="fig-table-link figpopup" rid-figpopup="metabolites-11-00025-f004" rid-ob="ob-metabolites-11-00025-f004" co-legend-rid="lgnd_metabolites-11-00025-f004"><span>Figure 4</span></a>). The myocardial infarction events were verified according to standardized WHO and MONICA criteria based on reports from hospitals or general practitioners, as well as hospital discharge records and death certificates [<a href="#B35-metabolites-11-00025" rid="B35-metabolites-11-00025" class=" bibr popnode">35</a>]. Only prospective cases of first myocardial infarction occurring after the health examination were included in the present study. Data collection included information on medical history, symptoms, examinations, and presenting ECG. ECGs were evaluated according to Minnesota code [<a href="#B36-metabolites-11-00025" rid="B36-metabolites-11-00025" class=" bibr popnode">36</a>], and the type of myocardial infarction was classified as STEMI or NSTEMI. If no ECG was available or the ST segment could not be evaluated (e.g., in the presence of a bundle branch block or a pacemaker), the case was classified as uncodable and not included in this study.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="metabolites-11-00025-f004" co-legend-rid="lgnd_metabolites-11-00025-f004"><a href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f004/" target="figure" rid-figpopup="metabolites-11-00025-f004" rid-ob="ob-metabolites-11-00025-f004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139930450620288"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7823877_metabolites-11-00025-g004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is metabolites-11-00025-g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7823877/bin/metabolites-11-00025-g004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139930450620288"><a target="object" rel="noopener" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_metabolites-11-00025-f004"><div><a class="figpopup" href="/pmc/articles/PMC7823877/figure/metabolites-11-00025-f004/" target="figure" rid-figpopup="metabolites-11-00025-f004" rid-ob="ob-metabolites-11-00025-f004">Figure 4</a></div><!--caption a7--><div class="caption"><p>Flow chart of the study population.</p></div></div></div><p class="p">We identified 469 participants (Dnr: 05-14M) with available plasma samples who developed a first-ever myocardial infarction after participation in population-based health examinations. According to ECG, 52% of the men and 48% of the women had STEMI, and 29% of the men and 28% of the women had NSTEMI. The remaining cases were uncodable. From this population, we selected the 50 youngest participants who developed STEMI and the 50 youngest who developed NSTEMI. For each case, one control was randomly selected from the participants in the same health examination as the case (VIP or MONICA) and individually matched for sex, age (&#x000b1;2 years), date of health examination (&#x000b1;4 months), and geographic region. As with the cases, the exclusion criteria for the control group were previous myocardial infarction or stroke and cancer. Controls were also excluded if they had died or moved out of the region before the date of diagnosis of the myocardial infarction for the corresponding case.</p><div id="sec4dot1-metabolites-11-00025" class="sec"><h3 id="sec4dot1-metabolites-11-00025title">4.1. Baseline Measurements</h3><p class="p p-first">Smoking habits were classified into &#x0201c;current daily smoking&#x0201d; or &#x0201c;nonsmoking&#x0201d; (including previous smokers and occasional smokers). Diabetes was defined as self-reported disease from the questionnaire or fasting glucose &#x02265;7 mmol/L and/or a 2-h post-load plasma glucose &#x02265;11.0 mmol/L (&#x02265;12.2 mmol/L in VIP, as capillary plasma was drawn). Education level was categorized into primary education or higher. Body mass index (BMI) was calculated as weight in kg/squared height in meters (kg/m<sup>2</sup>).</p><p class="p p-last">Venous blood samples were collected in evacuated glass tubes containing heparin using standardized procedures. The samples were centrifuged at 1500 g for 15 min to obtain heparinized plasma. In the VIP and MONICA cohorts, samples were collected in the morning, after at least 4 h of fasting. Cholesterol in venous blood at the time of the health examination was measured using enzymatic methods (Reflotron bench top analysers, Boehringer Mannheim GmbH, Mannheim, Germany). All samples were initially stored at &#x02212;20 &#x000b0;C (&#x0003c;7 days) and then &#x02212;80 &#x000b0;C at the Northern Sweden Medical Research Bank until metabolomics and protein analyses. ELISAs were performed to measure CRP (IMMULITE, Diagnostic Products Corporation, Los Angeles, CA, USA). ApoA1 and B were determined by immunoturbidimetry with reagents from Dako (Glostrup, Denmark) and a calibrator (X 0947) on a Hitachi 911 multianalyzer (Roche Diagnostics GmbH, Mannheim, Germany). The apoB/apoA1 ratio was calculated. Lipoprotein (a) were measured via an enzyme immunoassay (ELITEST-Lp [a], Paris, France) and an assay standards (Hyphern BioMed, Paris, France) antibody for detection.</p></div><div id="sec4dot2-metabolites-11-00025" class="sec"><h3 id="sec4dot2-metabolites-11-00025title">4.2. Metabolomics Analysis</h3><p class="p p-first">In view of known methodological biases, all samples were prepared and analyzed in a specific order, keeping paired samples close, but with a randomized internal order, and analytical batches were balanced according to the blinded infarction groups [<a href="#B37-metabolites-11-00025" rid="B37-metabolites-11-00025" class=" bibr popnode">37</a>]. Quality control samples pooled from all samples were included in each batch to assist with the identification of metabolites and to monitor instrument stability, exclude background features, and minimize methodological biases that could interfere with interpretation of the results.</p><p class="p p-last">The multiplatform metabolomics analyses included gas chromatography coupled with time-of-flight mass spectrometry (GC-TOF/MS) and liquid chromatography coupled with time-of-flight mass spectrometry (LC-TOF/MS, operating in positive and negative ion modes). Criteria set by the Human Metabolome Database (<a href="http://www.HMDB.ca">www.HMDB.ca</a>) were used to assign extracted putative metabolites to different compound classes (e.g., amino acids, carbohydrates, acylcarnitines, fatty acids, and lipid subtypes). Lysophospholipid ratios were calculated from lysophosphatidylcholines (LPCs) and lysophosphatidylethanolamines (LPEs) with identical fatty acid composition [<a href="#B24-metabolites-11-00025" rid="B24-metabolites-11-00025" class=" bibr popnode">24</a>]. Detailed sample preparation, the use of internal standards, analysis protocols, and subsequent data processing methods are provided in the <a href="#app1-metabolites-11-00025" rid="app1-metabolites-11-00025" class=" app">Supplementary Materials Table S1</a>.</p></div><div id="sec4dot3-metabolites-11-00025" class="sec"><h3 id="sec4dot3-metabolites-11-00025title">4.3. Protein Analysis</h3><p class="p p-first-last">Proteins were measured using the proximal extension assay (PEA) technique [<a href="#B38-metabolites-11-00025" rid="B38-metabolites-11-00025" class=" bibr popnode">38</a>] on a commercial proteomics array with 92 pre-selected proteins known or suggested to be involved in CVD (Olink Proseek Multiplex CVD I, Olink, Uppsala, Sweden). PEA is a homogeneous assay that utilizes pairs of antibodies equipped with DNA reporter molecules. When bound to their correct targets, the pairs give rise to new DNA amplicons that are subsequently quantified using a Fluidigm BioMark HD real-time PCR platform. Data are normalized and transformed using internal extension controls and inter-plate controls to adjust for intra- and inter-run variation [<a href="#B38-metabolites-11-00025" rid="B38-metabolites-11-00025" class=" bibr popnode">38</a>]. A complete list of all proteins included in this study is found in <a href="#app1-metabolites-11-00025" rid="app1-metabolites-11-00025" class=" app">Supplementary Materials Table S1</a>.</p></div><div id="sec4dot4-metabolites-11-00025" class="sec sec-last"><h3 id="sec4dot4-metabolites-11-00025title">4.4. Statistical Analysis</h3><p class="p p-first-last">All multivariate analyses (principal component analysis (PCA), orthogonal partial least squares (OPLS) and its extensions) [<a href="#B37-metabolites-11-00025" rid="B37-metabolites-11-00025" class=" bibr popnode">37</a>] were performed using the software package SIMCA version 15.02 (Umetrics, Ume&#x000e5;, Sweden). All comparisons were made group-wise; each myocardial infarction type was compared to individual age and sex-matched controls. To validate the multivariate models, <em>p</em>-values for the differences between the predefined classes (i.e., infarction group compared to their matched control group) were calculated by analysis of variance (ANOVA) based on the cross-validated OPLS scores (CV-ANOVA) [<a href="#B39-metabolites-11-00025" rid="B39-metabolites-11-00025" class=" bibr popnode">39</a>]. <em>p</em> &#x0003c; 0.05 was considered significant. Special consideration was made to ensure proper cross-validation groups (i.e., paired samples were kept in the same CV group) and reduce the risk of creating over-fitted models. If not stated otherwise, a metabolite was considered to contribute significantly to the metabolite profile if it was significantly altered according to the multivariate confidence interval based on jack-knifing [<a href="#B40-metabolites-11-00025" rid="B40-metabolites-11-00025" class=" bibr popnode">40</a>] and a significant univariate <em>p</em>-value on a 95% significance level. Univariate <em>p</em>-values were calculated using a paired <em>t</em> test on the putative metabolites highlighted by the multivariate models, as well as for the baseline clinical characteristics.</p></div></div><div id="sec5-metabolites-11-00025" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5-metabolites-11-00025title">5. Conclusions</h2><p class="p p-first-last">We show that STEMI and NSTEMI differ in their circulating metabolite and protein risk signatures. Individuals that will develop a STEMI have higher LPC:LPE ratios containing C18:2 fatty acid (linoleic acid), whereas the opposite is found in NSTEMI. Lysophospholipids actively mediate instable plaque formation [<a href="#B11-metabolites-11-00025" rid="B11-metabolites-11-00025" class=" bibr popnode">11</a>], which is in line with the finding of culprit plaques in STEMI [<a href="#B41-metabolites-11-00025" rid="B41-metabolites-11-00025" class=" bibr popnode">41</a>]. This is strengthened by our protein risk profile for STEMI, which included proteins highly associated with phospholipid metabolism, as well as increased thrombosis and plaque severity. In contrast, NSTEMI has a biochemical risk profile in line with their higher BMI compared to controls, which includes higher lysophospholipids, a branched-chain amino acid (valine), inflammatory markers, and proteins associated with increased macrophage infiltration.</p></div><div id="ack-a.k.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.k.atitle">Acknowledgments</h2><div class="sec"><p>We acknowledge personnel at the Swedish Metabolomics Centre for their assistance with mass spectrometry.</p></div></div><div id="app1-metabolites-11-00025" class="tsec sec"><h2 class="head no_bottom_margin" id="app1-metabolites-11-00025title">Supplementary Materials</h2><!--/article/back/app-group/app/--><p>The following are available online at <a href="https://www.mdpi.com/2218-1989/11/1/25/s1">https://www.mdpi.com/2218-1989/11/1/25/s1</a>, Supplementary material S1, Table S1: Putative metabolites and protein.</p><div class="sec suppmat" id="metabolites-11-00025-s001"><div class="sup-box half_rhythm" id="media-a.k.c.a.c.a"><a href="/pmc/articles/PMC7823877/bin/metabolites-11-00025-s001.zip" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(5.7M, zip)</sup></div></div></div><div id="notes-a.k.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.dtitle">Author Contributions</h2><p>All authors have participated sufficiently in the work represented by the article and take public responsibility for the content. Conceptualization E.C., J.-H.J, T.O. and P.W.; methodology: E.C.; writing&#x02014;original draft preparation: E.C.; writing&#x02014;review and editing: T.O., J.-H.J., P.W. All authors have read and agreed to the published version of the manuscript.</p></div><div id="notes-a.k.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.etitle">Funding</h2><p>This research was funded by the Swedish Heart and Lung Foundation, Region V&#x000e4;sterbotten, and Ume&#x000e5; University, Sweden.</p></div><div id="notes-a.k.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.ftitle">Institutional Review Board Statement</h2><p>The study was conducted according to the guidelines of the Declaration of Helsinki. Study approval was obtained from the Research Ethics Committee of Ume&#x000e5; University and the National Computer Inspection Bord, Sweden.</p></div><div id="notes-a.k.g" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.gtitle">Informed Consent Statement</h2><p>Informed consent was obtained from all subjects involved in the study.</p></div><div id="notes-a.k.h" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.htitle">Data Availability Statement</h2><p>Data will be available on request.</p></div><div id="notes-a.k.i" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.ititle">Conflicts of Interest</h2><p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></div><div id="fn-group-a.k.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.k.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.k.b.a"><p class="p p-first-last"><strong>Publisher&#x02019;s Note:</strong> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></p></div></div><div id="ref-list-a.k.j" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.k.jtitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1-metabolites-11-00025">1. <span class="element-citation">Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE) Castetbon K. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment. <span><span class="ref-journal">Lancet Diabetes Endocrinol. </span>2014;<span class="ref-vol">2</span>:634–647. doi: 10.1016/S2213-8587(14)70102-0.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4572741/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24842598" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS2213-8587(14)70102-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Diabetes+Endocrinol.&amp;title=Cardiovascular+disease,+chronic+kidney+disease,+and+diabetes+mortality+burden+of+cardiometabolic+risk+factors+from+1980+to+2010:+A+comparative+risk+assessment&amp;author=K.+Castetbon&amp;volume=2&amp;publication_year=2014&amp;pages=634-647&amp;pmid=24842598&amp;doi=10.1016/S2213-8587(14)70102-0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2-metabolites-11-00025">2. <span class="element-citation">Benziger C.P., Roth G.A., Moran A.E. The Global Burden of Disease Study and the Preventable Burden of NCD. <span><span class="ref-journal">Glob. Heart. </span>2016;<span class="ref-vol">11</span>:393–397. doi: 10.1016/j.gheart.2016.10.024.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27938824" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.gheart.2016.10.024" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Glob.+Heart&amp;title=The+Global+Burden+of+Disease+Study+and+the+Preventable+Burden+of+NCD&amp;author=C.P.+Benziger&amp;author=G.A.+Roth&amp;author=A.E.+Moran&amp;volume=11&amp;publication_year=2016&amp;pages=393-397&amp;pmid=27938824&amp;doi=10.1016/j.gheart.2016.10.024&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3-metabolites-11-00025">3. <span class="element-citation">Hamm C.W., Bassand J.-P., Agewall S., Bax J.J., Boersma E., Bueno H., Caso P., Dudek D., Gielen S., Huber K., et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) <span><span class="ref-journal">Eur. Heart J. </span>2011;<span class="ref-vol">32</span>:2999–3054. doi: 10.1093/eurheartj/ehr236.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21873419" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Feurheartj%2Fehr236" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+Heart+J.&amp;title=ESC+Guidelines+for+the+management+of+acute+coronary+syndromes+in+patients+presenting+without+persistent+ST-segment+elevation:+The+Task+Force+for+the+management+of+acute+coronary+syndromes+(ACS)+in+patients+presenting+without+persistent+ST-segment+elevation+of+the+European+Society+of+Cardiology+(ESC)&amp;author=C.W.+Hamm&amp;author=J.-P.+Bassand&amp;author=S.+Agewall&amp;author=J.J.+Bax&amp;author=E.+Boersma&amp;volume=32&amp;publication_year=2011&amp;pages=2999-3054&amp;pmid=21873419&amp;doi=10.1093/eurheartj/ehr236&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4-metabolites-11-00025">4. <span class="element-citation">Pasterkamp G., Den Ruijter H.M., Libby P. Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease. <span><span class="ref-journal">Nat. Rev. Cardiol. </span>2017;<span class="ref-vol">14</span>:21–29. doi: 10.1038/nrcardio.2016.166.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27762311" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrcardio.2016.166" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Cardiol.&amp;title=Temporal+shifts+in+clinical+presentation+and+underlying+mechanisms+of+atherosclerotic+disease&amp;author=G.+Pasterkamp&amp;author=H.M.+Den+Ruijter&amp;author=P.+Libby&amp;volume=14&amp;publication_year=2017&amp;pages=21-29&amp;pmid=27762311&amp;doi=10.1038/nrcardio.2016.166&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5-metabolites-11-00025">5. <span class="element-citation">Zaliaduonyte-Peksiene D., Lesauskaite V., Liutkevi&#x0010d;ien&#x00117; R., Tamakauskas V., Kviesulaitis V., Sinkunaite-Marsalkiene G., Simonyte S., Maciulskyte S., Tamuleviciute-Prasciene E., Gustiene O., et al. Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development. <span><span class="ref-journal">J. Renin-Angiotensin-Aldosterone Syst. </span>2017;<span class="ref-vol">18</span>:1470320317739987.  doi: 10.1177/1470320317739987.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5843915/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29141503" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F1470320317739987" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Renin-Angiotensin-Aldosterone+Syst.&amp;title=Association+of+the+genetic+and+traditional+risk+factors+of+ischaemic+heart+disease+with+STEMI+and+NSTEMI+development&amp;author=D.+Zaliaduonyte-Peksiene&amp;author=V.+Lesauskaite&amp;author=R.+Liutkevi&#x0010d;ien&#x00117;&amp;author=V.+Tamakauskas&amp;author=V.+Kviesulaitis&amp;volume=18&amp;publication_year=2017&amp;pages=1470320317739987&amp;pmid=29141503&amp;doi=10.1177/1470320317739987&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6-metabolites-11-00025">6. <span class="element-citation">Anderson K.M., Odell P.M., Wilson P.W., Kannel W.B. Cardiovascular disease risk profiles. <span><span class="ref-journal">Am. Heart J. </span>1991;<span class="ref-vol">121</span>:293–298. doi: 10.1016/0002-8703(91)90861-B.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1985385" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0002-8703(91)90861-B" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+Heart+J.&amp;title=Cardiovascular+disease+risk+profiles&amp;author=K.M.+Anderson&amp;author=P.M.+Odell&amp;author=P.W.+Wilson&amp;author=W.B.+Kannel&amp;volume=121&amp;publication_year=1991&amp;pages=293-298&amp;pmid=1985385&amp;doi=10.1016/0002-8703(91)90861-B&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7-metabolites-11-00025">7. <span class="element-citation">Jneid H., Addison D., Bhatt D.L., Fonarow G.C., Gokak S., Grady K.L., Green L.A., A Heidenreich P., Ho P.M., Jurgens C.Y., et al. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non&#x02013;ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. <span><span class="ref-journal">Circ. Cardiovasc. Qual. Outcomes. </span>2017;<span class="ref-vol">10</span>:e000032.  doi: 10.1161/HCQ.0000000000000032.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28935817" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FHCQ.0000000000000032" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ.+Cardiovasc.+Qual.+Outcomes&amp;title=2017+AHA/ACC+Clinical+Performance+and+Quality+Measures+for+Adults+With+ST-Elevation+and+Non&#x02013;ST-Elevation+Myocardial+Infarction:+A+Report+of+the+American+College+of+Cardiology/American+Heart+Association+Task+Force+on+Performance+Measures&amp;author=H.+Jneid&amp;author=D.+Addison&amp;author=D.L.+Bhatt&amp;author=G.C.+Fonarow&amp;author=S.+Gokak&amp;volume=10&amp;publication_year=2017&amp;pages=e000032&amp;pmid=28935817&amp;doi=10.1161/HCQ.0000000000000032&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8-metabolites-11-00025">8. <span class="element-citation">Law S.-H., Chan M.-L., Marathe G.K., Parveen F., Chen C.-H., Ke L.-Y. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2019;<span class="ref-vol">20</span>:1149.  doi: 10.3390/ijms20051149.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6429061/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30845751" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms20051149" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=An+Updated+Review+of+Lysophosphatidylcholine+Metabolism+in+Human+Diseases&amp;author=S.-H.+Law&amp;author=M.-L.+Chan&amp;author=G.K.+Marathe&amp;author=F.+Parveen&amp;author=C.-H.+Chen&amp;volume=20&amp;publication_year=2019&amp;pages=1149&amp;doi=10.3390/ijms20051149&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9-metabolites-11-00025">9. <span class="element-citation">Schober A., Siess W. Lysophosphatidic acid in atherosclerotic diseases. <span><span class="ref-journal">Br. J. Pharmacol. </span>2012;<span class="ref-vol">167</span>:465–482. doi: 10.1111/j.1476-5381.2012.02021.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3449253/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22568609" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1476-5381.2012.02021.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br.+J.+Pharmacol.&amp;title=Lysophosphatidic+acid+in+atherosclerotic+diseases&amp;author=A.+Schober&amp;author=W.+Siess&amp;volume=167&amp;publication_year=2012&amp;pages=465-482&amp;pmid=22568609&amp;doi=10.1111/j.1476-5381.2012.02021.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10-metabolites-11-00025">10. <span class="element-citation">Fourcade O., Simon M.-F., Viod&#x000e9; C., Rugani N., Leballe F., Ragab A., Fourni&#x000e9; B., Sarda L., Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. <span><span class="ref-journal">Cell. </span>1995;<span class="ref-vol">80</span>:919–927. doi: 10.1016/0092-8674(95)90295-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7697722" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0092-8674(95)90295-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Secretory+phospholipase+A2+generates+the+novel+lipid+mediator+lysophosphatidic+acid+in+membrane+microvesicles+shed+from+activated+cells&amp;author=O.+Fourcade&amp;author=M.-F.+Simon&amp;author=C.+Viod&#x000e9;&amp;author=N.+Rugani&amp;author=F.+Leballe&amp;volume=80&amp;publication_year=1995&amp;pages=919-927&amp;pmid=7697722&amp;doi=10.1016/0092-8674(95)90295-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11-metabolites-11-00025">11. <span class="element-citation">Diehl P., Nienaber F., Zaldivia M.T.K., Stamm J., Siegel P.M., Mellett N.A., Wessinger M., Wang X., McFadyen J.D., Bassler N., et al. Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability. <span><span class="ref-journal">Thromb. Haemost. </span>2019;<span class="ref-vol">119</span>:1295–1310. doi: 10.1055/s-0039-1683409.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31378855" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1055%2Fs-0039-1683409" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thromb.+Haemost.&amp;title=Lysophosphatidylcholine+is+a+Major+Component+of+Platelet+Microvesicles+Promoting+Platelet+Activation+and+Reporting+Atherosclerotic+Plaque+Instability&amp;author=P.+Diehl&amp;author=F.+Nienaber&amp;author=M.T.K.+Zaldivia&amp;author=J.+Stamm&amp;author=P.M.+Siegel&amp;volume=119&amp;publication_year=2019&amp;pages=1295-1310&amp;pmid=31378855&amp;doi=10.1055/s-0039-1683409&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12-metabolites-11-00025">12. <span class="element-citation">Wennberg P., Wensley F., Di Angelantonio E., Johansson L., Boman K., Rumley A., Lowe G., Hallmans G., Danesh J., Jansson J.-H. Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women. <span><span class="ref-journal">Thromb. Res. </span>2012;<span class="ref-vol">129</span>:68–73. doi: 10.1016/j.thromres.2011.05.015.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21641633" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.thromres.2011.05.015" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thromb.+Res.&amp;title=Haemostatic+and+inflammatory+markers+are+independently+associated+with+myocardial+infarction+in+men+and+women&amp;author=P.+Wennberg&amp;author=F.+Wensley&amp;author=E.+Di+Angelantonio&amp;author=L.+Johansson&amp;author=K.+Boman&amp;volume=129&amp;publication_year=2012&amp;pages=68-73&amp;pmid=21641633&amp;doi=10.1016/j.thromres.2011.05.015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13-metabolites-11-00025">13. <span class="element-citation">Evangelou A. Platelet-activating factor (PAF): Implications for coronary heart and vascular diseases. <span><span class="ref-journal">Prostaglandins Leukot. Essent. Fat. Acids. </span>1994;<span class="ref-vol">50</span>:1–28. doi: 10.1016/0952-3278(94)90101-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8146205" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0952-3278(94)90101-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukot.+Essent.+Fat.+Acids&amp;title=Platelet-activating+factor+(PAF):+Implications+for+coronary+heart+and+vascular+diseases&amp;author=A.+Evangelou&amp;volume=50&amp;publication_year=1994&amp;pages=1-28&amp;doi=10.1016/0952-3278(94)90101-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14-metabolites-11-00025">14. <span class="element-citation">Kurano M., Kano K., Dohi T., Matsumoto H., Igarashi K., Nishikawa M., Ohkawa R., Ikeda H., Miyauchi K., Daida H., et al. Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome. <span><span class="ref-journal">J. Lipid Res. </span>2017;<span class="ref-vol">58</span>:433–442. doi: 10.1194/jlr.P071803.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5282959/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28007846" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1194%2Fjlr.P071803" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Lipid+Res.&amp;title=Different+origins+of+lysophospholipid+mediators+between+coronary+and+peripheral+arteries+in+acute+coronary+syndrome&amp;author=M.+Kurano&amp;author=K.+Kano&amp;author=T.+Dohi&amp;author=H.+Matsumoto&amp;author=K.+Igarashi&amp;volume=58&amp;publication_year=2017&amp;pages=433-442&amp;pmid=28007846&amp;doi=10.1194/jlr.P071803&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15-metabolites-11-00025">15. <span class="element-citation">Morisawa T., Nakagomi A., Kohashi K., Kusama Y., Shimizu W. Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease. <span><span class="ref-journal">J. Atheroscler. Thromb. </span>2017;<span class="ref-vol">24</span>:1058–1068. doi: 10.5551/jat.39339.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5656768/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28428481" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5551%2Fjat.39339" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Atheroscler.+Thromb.&amp;title=Serum+Tartrate-resistant+Acid+Phosphatase-5b+Levels+are+Associated+with+the+Severity+and+Extent+of+Coronary+Atherosclerosis+in+Patients+with+Coronary+Artery+Disease&amp;author=T.+Morisawa&amp;author=A.+Nakagomi&amp;author=K.+Kohashi&amp;author=Y.+Kusama&amp;author=W.+Shimizu&amp;volume=24&amp;publication_year=2017&amp;pages=1058-1068&amp;pmid=28428481&amp;doi=10.5551/jat.39339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16-metabolites-11-00025">16. <span class="element-citation">Cai Y., Winn M.E., Zehmer J.K., Gillette W.K., Lubkowski J.T., Pilon A.L., Kimura S. Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis. <span><span class="ref-journal">Am. J. Physiol. Cell. Mol. Physiol. </span>2014;<span class="ref-vol">306</span>:L10–L22. doi: 10.1152/ajplung.00037.2013.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3920213/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24213919" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1152%2Fajplung.00037.2013" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Physiol.+Cell.+Mol.+Physiol.&amp;title=Preclinical+evaluation+of+human+secretoglobin+3A2+in+mouse+models+of+lung+development+and+fibrosis&amp;author=Y.+Cai&amp;author=M.E.+Winn&amp;author=J.K.+Zehmer&amp;author=W.K.+Gillette&amp;author=J.T.+Lubkowski&amp;volume=306&amp;publication_year=2014&amp;pages=L10-L22&amp;pmid=24213919&amp;doi=10.1152/ajplung.00037.2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17-metabolites-11-00025">17. <span class="element-citation">Li L., Blumenthal D.K., Terry C.M., He Y., Carlson M.L., Cheung A.K. PDGF-induced proliferation in human arterial and venous smooth muscle cells: Molecular basis for differential effects of PDGF isoforms. <span><span class="ref-journal">J. Cell. Biochem. </span>2010;<span class="ref-vol">112</span>:289–298. doi: 10.1002/jcb.22924.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4454503/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21069732" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjcb.22924" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Cell.+Biochem.&amp;title=PDGF-induced+proliferation+in+human+arterial+and+venous+smooth+muscle+cells:+Molecular+basis+for+differential+effects+of+PDGF+isoforms&amp;author=L.+Li&amp;author=D.K.+Blumenthal&amp;author=C.M.+Terry&amp;author=Y.+He&amp;author=M.L.+Carlson&amp;volume=112&amp;publication_year=2010&amp;pages=289-298&amp;pmid=21069732&amp;doi=10.1002/jcb.22924&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18-metabolites-11-00025">18. <span class="element-citation">De Leon M.P., Carubbi F., Di Donato P., Carulli N., De Leon M.P. Cholesterol esterase activity of human intestinal mucosa. <span><span class="ref-journal">Dig. Dis. Sci. </span>1985;<span class="ref-vol">30</span>:1053–1064. doi: 10.1007/BF01315603.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/4053916" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2FBF01315603" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dig.+Dis.+Sci.&amp;title=Cholesterol+esterase+activity+of+human+intestinal+mucosa&amp;author=M.P.+De+Leon&amp;author=F.+Carubbi&amp;author=P.+Di+Donato&amp;author=N.+Carulli&amp;author=M.P.+De+Leon&amp;volume=30&amp;publication_year=1985&amp;pages=1053-1064&amp;pmid=4053916&amp;doi=10.1007/BF01315603&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19-metabolites-11-00025">19. <span class="element-citation">Rodrigues C.M., Sola S., Nan Z., Castro R.E., Ribeiro P.S., Low W.C., Steer C.J. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>2003;<span class="ref-vol">100</span>:6087–6092. doi: 10.1073/pnas.1031632100.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC156330/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12721362" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.1031632100" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Tauroursodeoxycholic+acid+reduces+apoptosis+and+protects+against+neurological+injury+after+acute+hemorrhagic+stroke+in+rats&amp;author=C.M.+Rodrigues&amp;author=S.+Sola&amp;author=Z.+Nan&amp;author=R.E.+Castro&amp;author=P.S.+Ribeiro&amp;volume=100&amp;publication_year=2003&amp;pages=6087-6092&amp;pmid=12721362&amp;doi=10.1073/pnas.1031632100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20-metabolites-11-00025">20. <span class="element-citation">Graf D., Kurz A.K., Reinehr R., Fischer R., Kircheis G., H&#x000e4;ussinger D. Prevention of bile acid-induced apoptosis by betaine in rat liver. <span><span class="ref-journal">Hepatology. </span>2002;<span class="ref-vol">36</span>:829–839. doi: 10.1053/jhep.2002.35536.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12297830" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1053%2Fjhep.2002.35536" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Prevention+of+bile+acid-induced+apoptosis+by+betaine+in+rat+liver&amp;author=D.+Graf&amp;author=A.K.+Kurz&amp;author=R.+Reinehr&amp;author=R.+Fischer&amp;author=G.+Kircheis&amp;volume=36&amp;publication_year=2002&amp;pages=829-839&amp;pmid=12297830&amp;doi=10.1053/jhep.2002.35536&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21-metabolites-11-00025">21. <span class="element-citation">Ellulu M.S., Patimah I., Khaza&#x02019;Ai H., Rahmat A., Abed Y. Obesity and inflammation: The linking mechanism and the complications. <span><span class="ref-journal">Arch. Med. Sci. </span>2017;<span class="ref-vol">4</span>:851–863. doi: 10.5114/aoms.2016.58928.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5507106/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28721154" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5114%2Faoms.2016.58928" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Med.+Sci.&amp;title=Obesity+and+inflammation:+The+linking+mechanism+and+the+complications&amp;author=M.S.+Ellulu&amp;author=I.+Patimah&amp;author=H.+Khaza&#x02019;Ai&amp;author=A.+Rahmat&amp;author=Y.+Abed&amp;volume=4&amp;publication_year=2017&amp;pages=851-863&amp;pmid=28721154&amp;doi=10.5114/aoms.2016.58928&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22-metabolites-11-00025">22. <span class="element-citation">Meikle P.J., Summers S.A. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. <span><span class="ref-journal">Nat. Rev. Endocrinol. </span>2017;<span class="ref-vol">13</span>:79–91. doi: 10.1038/nrendo.2016.169.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27767036" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrendo.2016.169" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Endocrinol.&amp;title=Sphingolipids+and+phospholipids+in+insulin+resistance+and+related+metabolic+disorders&amp;author=P.J.+Meikle&amp;author=S.A.+Summers&amp;volume=13&amp;publication_year=2017&amp;pages=79-91&amp;pmid=27767036&amp;doi=10.1038/nrendo.2016.169&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23-metabolites-11-00025">23. <span class="element-citation">Park J.Y., Lee S.-H., Shin M.-J., Hwang G.-S. Alteration in Metabolic Signature and Lipid Metabolism in Patients with Angina Pectoris and Myocardial Infarction. <span><span class="ref-journal">PLoS ONE. </span>2015;<span class="ref-vol">10</span>:e0135228.  doi: 10.1371/journal.pone.0135228.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4530944/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26258408" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0135228" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Alteration+in+Metabolic+Signature+and+Lipid+Metabolism+in+Patients+with+Angina+Pectoris+and+Myocardial+Infarction&amp;author=J.Y.+Park&amp;author=S.-H.+Lee&amp;author=M.-J.+Shin&amp;author=G.-S.+Hwang&amp;volume=10&amp;publication_year=2015&amp;pages=e0135228&amp;pmid=26258408&amp;doi=10.1371/journal.pone.0135228&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24-metabolites-11-00025">24. <span class="element-citation">Van Der Veen J.N., Kennelly J.P., Wan S., Vance J.E., Vance D.E., Jacobs R.L. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. <span><span class="ref-journal">Biochim. Biophys. Acta (BBA) Biomembr. </span>2017;<span class="ref-vol">1859</span>:1558–1572. doi: 10.1016/j.bbamem.2017.04.006.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28411170" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbamem.2017.04.006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta+(BBA)+Biomembr.&amp;title=The+critical+role+of+phosphatidylcholine+and+phosphatidylethanolamine+metabolism+in+health+and+disease&amp;author=J.N.+Van+Der+Veen&amp;author=J.P.+Kennelly&amp;author=S.+Wan&amp;author=J.E.+Vance&amp;author=D.E.+Vance&amp;volume=1859&amp;publication_year=2017&amp;pages=1558-1572&amp;pmid=28411170&amp;doi=10.1016/j.bbamem.2017.04.006&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25-metabolites-11-00025">25. <span class="element-citation">Levkau B. HDL-S1P: Cardiovascular functions, disease-associated alterations, and therapeutic applications. <span><span class="ref-journal">Front. Pharmacol. </span>2015;<span class="ref-vol">6</span>:243. doi: 10.3389/fphar.2015.00243.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4611146/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26539121" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2015.00243" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Pharmacol.&amp;title=HDL-S1P:+Cardiovascular+functions,+disease-associated+alterations,+and+therapeutic+applications&amp;author=B.+Levkau&amp;volume=6&amp;publication_year=2015&amp;pages=243&amp;pmid=26539121&amp;doi=10.3389/fphar.2015.00243&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26-metabolites-11-00025">26. <span class="element-citation">Morris T.G., Borland S.J., Clarke C.J., Wilson C., Hannun Y.A., Ohanian V., Canfield A.E., Ohanian J. Sphingosine 1-phosphate activation of ERM contributes to vascular calcification. <span><span class="ref-journal">J. Lipid Res. </span>2017;<span class="ref-vol">59</span>:69–78. doi: 10.1194/jlr.M079731.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5748498/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29167409" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1194%2Fjlr.M079731" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Lipid+Res.&amp;title=Sphingosine+1-phosphate+activation+of+ERM+contributes+to+vascular+calcification&amp;author=T.G.+Morris&amp;author=S.J.+Borland&amp;author=C.J.+Clarke&amp;author=C.+Wilson&amp;author=Y.A.+Hannun&amp;volume=59&amp;publication_year=2017&amp;pages=69-78&amp;pmid=29167409&amp;doi=10.1194/jlr.M079731&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27-metabolites-11-00025">27. <span class="element-citation">Alewijnse A.E., Peters S.L. Sphingolipid signalling in the cardiovascular system: Good, bad or both? <span><span class="ref-journal">Eur. J. Pharmacol. </span>2008;<span class="ref-vol">585</span>:292–302. doi: 10.1016/j.ejphar.2008.02.089.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18420192" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ejphar.2008.02.089" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Pharmacol.&amp;title=Sphingolipid+signalling+in+the+cardiovascular+system:+Good,+bad+or+both?&amp;author=A.E.+Alewijnse&amp;author=S.L.+Peters&amp;volume=585&amp;publication_year=2008&amp;pages=292-302&amp;pmid=18420192&amp;doi=10.1016/j.ejphar.2008.02.089&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28-metabolites-11-00025">28. <span class="element-citation">Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., Haqq A.M., Shah S.H., Arlotto M., Slentz C.A., et al. A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance. <span><span class="ref-journal">Cell Metab. </span>2009;<span class="ref-vol">9</span>:311–326. doi: 10.1016/j.cmet.2009.02.002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3640280/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19356713" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cmet.2009.02.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab.&amp;title=A+Branched-Chain+Amino+Acid-Related+Metabolic+Signature+that+Differentiates+Obese+and+Lean+Humans+and+Contributes+to+Insulin+Resistance&amp;author=C.B.+Newgard&amp;author=J.+An&amp;author=J.R.+Bain&amp;author=M.J.+Muehlbauer&amp;author=R.D.+Stevens&amp;volume=9&amp;publication_year=2009&amp;pages=311-326&amp;pmid=19356713&amp;doi=10.1016/j.cmet.2009.02.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29-metabolites-11-00025">29. <span class="element-citation">Wischmeyer P.E., Jayakar D., Williams U., Singleton K., Riehm J., Bacha E., Jeevanandam V., Christians U., Serkova N. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. <span><span class="ref-journal">J. Parenter. Enter. Nutr. </span>2003;<span class="ref-vol">27</span>:396–403. doi: 10.1177/0148607103027006396.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14621120" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0148607103027006396" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Parenter.+Enter.+Nutr.&amp;title=Single+dose+of+glutamine+enhances+myocardial+tissue+metabolism,+glutathione+content,+and+improves+myocardial+function+after+ischemia-reperfusion+injury&amp;author=P.E.+Wischmeyer&amp;author=D.+Jayakar&amp;author=U.+Williams&amp;author=K.+Singleton&amp;author=J.+Riehm&amp;volume=27&amp;publication_year=2003&amp;pages=396-403&amp;doi=10.1177/0148607103027006396&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30-metabolites-11-00025">30. <span class="element-citation">Nickel A., L&#x000f6;ffler J., Maack C. Myocardial energetics in heart failure. <span><span class="ref-journal">Basic Res. Cardiol. </span>2013;<span class="ref-vol">108</span>:1–20. doi: 10.1007/s00395-013-0358-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23740216" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00395-013-0358-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Basic+Res.+Cardiol.&amp;title=Myocardial+energetics+in+heart+failure&amp;author=A.+Nickel&amp;author=J.+L&#x000f6;ffler&amp;author=C.+Maack&amp;volume=108&amp;publication_year=2013&amp;pages=1-20&amp;doi=10.1007/s00395-013-0358-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31-metabolites-11-00025">31. <span class="element-citation">Makrecka-Kuka M., Sevostjanovs E., Vilks K., Volska K., Antone U., Kuka J., Makarova E., Pugovics O., Dambrova M., Liepinsh E. Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. <span><span class="ref-journal">Sci. Rep. </span>2017;<span class="ref-vol">7</span>:1–11. doi: 10.1038/s41598-017-17797-x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5727517/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29235526" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-017-17797-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=Plasma+acylcarnitine+concentrations+reflect+the+acylcarnitine+profile+in+cardiac+tissues&amp;author=M.+Makrecka-Kuka&amp;author=E.+Sevostjanovs&amp;author=K.+Vilks&amp;author=K.+Volska&amp;author=U.+Antone&amp;volume=7&amp;publication_year=2017&amp;pages=1-11&amp;pmid=28127051&amp;doi=10.1038/s41598-017-17797-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32-metabolites-11-00025">32. <span class="element-citation">McCoin C.S., Knotts T.A., Adams S.H. Acylcarnitines&#x02014;Old actors auditioning for new roles in metabolic physiology. <span><span class="ref-journal">Nat. Rev. Endocrinol. </span>2015;<span class="ref-vol">11</span>:617–625. doi: 10.1038/nrendo.2015.129.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4966159/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26303601" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrendo.2015.129" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Endocrinol.&amp;title=Acylcarnitines&#x02014;Old+actors+auditioning+for+new+roles+in+metabolic+physiology&amp;author=C.S.+McCoin&amp;author=T.A.+Knotts&amp;author=S.H.+Adams&amp;volume=11&amp;publication_year=2015&amp;pages=617-625&amp;pmid=26303601&amp;doi=10.1038/nrendo.2015.129&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33-metabolites-11-00025">33. <span class="element-citation">Eriksson M., Forslund A.-S., Jansson J.-H., Soederberg S., Wennberg M., Eliasson M. Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population: The northern Sweden MONICA study 1994 to 2014. <span><span class="ref-journal">Eur. Heart J. </span>2016;<span class="ref-vol">37</span>:1985–1992. doi: 10.1093/eurheartj/ehw052.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4929376/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26941200" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Feurheartj%2Fehw052" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+Heart+J.&amp;title=Greater+decreases+in+cholesterol+levels+among+individuals+with+high+cardiovascular+risk+than+among+the+general+population:+The+northern+Sweden+MONICA+study+1994+to+2014&amp;author=M.+Eriksson&amp;author=A.-S.+Forslund&amp;author=J.-H.+Jansson&amp;author=S.+Soederberg&amp;author=M.+Wennberg&amp;volume=37&amp;publication_year=2016&amp;pages=1985-1992&amp;pmid=26941200&amp;doi=10.1093/eurheartj/ehw052&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34-metabolites-11-00025">34. <span class="element-citation">Norberg M., Wall S., Boman K., Weinehall L. The V&#x000e4;sterbotten Intervention Programme: Background, design and implications. <span><span class="ref-journal">Glob. Health Action. </span>2010;<span class="ref-vol">3</span>:34. doi: 10.3402/gha.v3i0.4643.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2844807/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20339479" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3402%2Fgha.v3i0.4643" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Glob.+Health+Action&amp;title=The+V&#x000e4;sterbotten+Intervention+Programme:+Background,+design+and+implications&amp;author=M.+Norberg&amp;author=S.+Wall&amp;author=K.+Boman&amp;author=L.+Weinehall&amp;volume=3&amp;publication_year=2010&amp;pages=34&amp;pmid=20339479&amp;doi=10.3402/gha.v3i0.4643&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35-metabolites-11-00025">35. <span class="element-citation">Stegmayr B., Lundberg V., Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. <span><span class="ref-journal">Scand. J. Public Health. </span>2003;<span class="ref-vol">31</span>:9–17. doi: 10.1080/14034950310001441.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14660242" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F14034950310001441" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand.+J.+Public+Health&amp;title=The+events+registration+and+survey+procedures+in+the+Northern+Sweden+MONICA+Project&amp;author=B.+Stegmayr&amp;author=V.+Lundberg&amp;author=K.+Asplund&amp;volume=31&amp;publication_year=2003&amp;pages=9-17&amp;doi=10.1080/14034950310001441&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36-metabolites-11-00025">36. <span class="element-citation">Prineas R., Crow R., Blackburn H.  <span class="ref-journal">The Minnesota Code Manual of Electrocardiographic Findings.</span> John Wright-PSG, Inc.; Littleton, MA, USA: 1982.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=The+Minnesota+Code+Manual+of+Electrocardiographic+Findings&amp;author=R.+Prineas&amp;author=R.+Crow&amp;author=H.+Blackburn&amp;publication_year=1982&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37-metabolites-11-00025">37. <span class="element-citation">Jonsson P., Wuolikainen A., Thysell E., Chorell E., Stattin P., Wikstr&#x000f6;m P., Antti H. Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. <span><span class="ref-journal">Metabolomics. </span>2015;<span class="ref-vol">11</span>:1667–1678. doi: 10.1007/s11306-015-0818-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4605978/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26491420" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs11306-015-0818-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Metabolomics&amp;title=Constrained+randomization+and+multivariate+effect+projections+improve+information+extraction+and+biomarker+pattern+discovery+in+metabolomics+studies+involving+dependent+samples&amp;author=P.+Jonsson&amp;author=A.+Wuolikainen&amp;author=E.+Thysell&amp;author=E.+Chorell&amp;author=P.+Stattin&amp;volume=11&amp;publication_year=2015&amp;pages=1667-1678&amp;pmid=26491420&amp;doi=10.1007/s11306-015-0818-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38-metabolites-11-00025">38. <span class="element-citation">Assarsson E., Lundberg M., Holmquist G., Bj&#x000f6;rkesten J., Thorsen S.B., Ekman D., Eriksson A., Dickens E.R., Ohlsson S., Edfeldt G., et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability. <span><span class="ref-journal">PLoS ONE. </span>2014;<span class="ref-vol">9</span>:e95192.  doi: 10.1371/journal.pone.0095192.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3995906/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24755770" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0095192" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Homogenous+96-Plex+PEA+Immunoassay+Exhibiting+High+Sensitivity,+Specificity,+and+Excellent+Scalability&amp;author=E.+Assarsson&amp;author=M.+Lundberg&amp;author=G.+Holmquist&amp;author=J.+Bj&#x000f6;rkesten&amp;author=S.B.+Thorsen&amp;volume=9&amp;publication_year=2014&amp;pages=e95192&amp;pmid=24755770&amp;doi=10.1371/journal.pone.0095192&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39-metabolites-11-00025">39. <span class="element-citation">Lennart Eriksson J.T. Svante Wold CV-ANOVA for significance testing of PLS and OPLS models. <span><span class="ref-journal">J. Chemo Metr. </span>2008;<span class="ref-vol">22</span>:594–600. doi: 10.1002/cem.1187.</span> [<a href="//doi.org/10.1002%2Fcem.1187" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Chemo+Metr.&amp;title=Svante+Wold+CV-ANOVA+for+significance+testing+of+PLS+and+OPLS+models&amp;author=J.T.+Lennart+Eriksson&amp;volume=22&amp;publication_year=2008&amp;pages=594-600&amp;doi=10.1002/cem.1187&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40-metabolites-11-00025">40. <span class="element-citation">Efron B., Gong G. A Leisurely Look at the Bootstrap, the Jack-knife, and Cross-validation. <span><span class="ref-journal">Am. Stat. </span>1983;<span class="ref-vol">37</span>:36–48.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+Stat.&amp;title=A+Leisurely+Look+at+the+Bootstrap,+the+Jack-knife,+and+Cross-validation&amp;author=B.+Efron&amp;author=G.+Gong&amp;volume=37&amp;publication_year=1983&amp;pages=36-48&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41-metabolites-11-00025">41. <span class="element-citation">Bom M.J., Van Der Heijden D.J., Kedhi E., Van Der Heyden J., Meuwissen M., Knaapen P., Timmer S.A., Van Royen N. Early Detection and Treatment of the Vulnerable Coronary Plaque. <span><span class="ref-journal">Circ. Cardiovasc. Imaging. </span>2017;<span class="ref-vol">10</span> doi: 10.1161/CIRCIMAGING.116.005973.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28483945" ref="reftype=pubmed&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCIMAGING.116.005973" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ.+Cardiovasc.+Imaging&amp;title=Early+Detection+and+Treatment+of+the+Vulnerable+Coronary+Plaque&amp;author=M.J.+Bom&amp;author=D.J.+Van+Der+Heijden&amp;author=E.+Kedhi&amp;author=J.+Van+Der+Heyden&amp;author=M.+Meuwissen&amp;volume=10&amp;publication_year=2017&amp;doi=10.1161/CIRCIMAGING.116.005973&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7823877&amp;issue-id=373595&amp;journal-id=2273&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Metabolites</span> are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC7823877/pdf/metabolites-11-00025.pdf" class="int-view">PDF (2.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7823877/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7823877/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="7823877" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7823877%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="jMtTggGlnGU5ByT6Le6AS9rmd60VX3vjI8OmcJcfy98ZGcVIayRcD55dYHMMbD3L">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7823877%2F&amp;text=Lysophospholipids%20as%20Predictive%20Markers%20of%20ST-Elevation%20Myocardial%20Infarction%20(STEMI)%20and%20Non-ST-Elevation%20Myocardial%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7823877%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823877/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7823877/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/33396480/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7823877/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/33396480/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7823877/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7823877/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC7823877/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
